Mwanda W O, Rajab J A
Department of Haematology and Blood Transfusion, College of Health Sciences, University of Nairobi.
East Afr Med J. 1999 Oct;76(10):594-6.
Granulocytic sarcoma (GS) is a rare extramedullary solid tumour composed of malignant immature cells of the granulocytic series. It may herald, accompany or signal acute myeloid leukaemia (AML) or chronic granulocytic leukaemia (CGL). GS may also occur in patients with myelodysplastic syndromes (MDS) where it is a sign of imminent disease progression. Three cases of GS are presented; the first one involving the pancreas and preceding AML, the second case affecting uterine cervix in stable phase CGL and the third case is GS of the breast accompanying AML. Any site of the body may be involved by the GS, and morbidity depends on the local organ/tissue affected in addition to the attending primary leukaemia or MDS. Treatment of GS involves surgery, radiotherapy and chemotherapy. The objective of this communication is to enhance awareness in personnel providing health care. Further, early diagnosis and treatment affects overall outcome.
粒细胞肉瘤(GS)是一种罕见的髓外实体瘤,由粒细胞系的恶性未成熟细胞组成。它可能预示、伴随或提示急性髓系白血病(AML)或慢性粒细胞白血病(CGL)。GS也可能发生在骨髓增生异常综合征(MDS)患者中,是疾病即将进展的标志。本文介绍了3例GS病例;第一例累及胰腺且先于AML出现,第二例在CGL稳定期累及子宫颈,第三例是伴随AML的乳腺GS。GS可累及身体的任何部位,除了伴发的原发性白血病或MDS外,发病率还取决于受影响的局部器官/组织。GS的治疗包括手术、放疗和化疗。本文的目的是提高医疗保健人员的认识。此外,早期诊断和治疗会影响总体预后。